Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Antiviral Res. 2013 Mar 21;98(2):135–143. doi: 10.1016/j.antiviral.2013.03.009

Figure 7. Analysis of tissue viral titers and histopathology in survivors and moribund mice treated with rMP12-C13type or rMP12-mPKRN167 RVFV vaccine viruses at 30 minutes post-exposure.

Figure 7

Five mice survived the 21-day observation period. One mouse vaccinated with rMP12-mPKRN167 that became moribund on day 17 was also included. Shown are data for A) spleen, and B) brain virus titers, and C) histopathology of the brain. The gray hashed lines indicate the limits of detection. Unique symbols in each treatment group represent values for the same animal across all parameters.